ONC Q2 2017 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q2 2017 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$47M

Operating Income

-$58M

Net Income

-$61M

EPS (Diluted)

$-1.56

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$66M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$474M

Total Liabilities

$204M

Stockholders' Equity

$256M

Cash & Equivalents

$261M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$393,000	-100.0%
Gross Profit	-$47M	-$21M	-128.0%
Operating Income	-$58M	-$25M	-135.6%
Net Income	-$61M	-$24M	-151.0%